Division of Translational Cancer Research
41 – 50 of 671
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
- Contribution to journal › Article
-
Mark
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma
- Contribution to journal › Article
-
Mark
Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing
- Contribution to journal › Article
-
Mark
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
- Contribution to journal › Article
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
- Contribution to journal › Article
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
- Contribution to journal › Article
-
Mark
Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma
(2024) In Proceedings of the National Academy of Sciences of the United States of America 121(7). p.2310479121-2310479121
- Contribution to journal › Article
-
Mark
Current and emerging sequencing-based tools for precision cancer medicine
- Contribution to journal › Scientific review
-
Mark
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
- Contribution to journal › Article
-
Mark
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
- Contribution to journal › Scientific review
